This video was recorded at View Point Vancouver, which took place on April 20, 2024.
Dr. Paul Yang is chief of the Paul H. Casey Ophthalmic Genetics Division and Martha and Eddie Peterson Endowed Professor at OHSU Casey Eye Institute in Portland, Oregon. He is also principal investigator on multiple industry-sponsored retinal gene therapy clinical trials for inherited retinal degenerations. In this keynote presentation, Dr. Yang will describe what gene therapy is and how it works. He will provide an update on the first gene therapy available for an eye disease and outline what other potential treatments are in clinical trials.
View Point is proudly presented by Bayer and supported by Abbvie, Apellis, Astellas, Biogen, Janssen, Novartis and Roche.
To learn more visit www.fightingbl...
STAY CONNECTED
Facebook: / fightingblindnesscanada
Instagram: / fightingblindnessca
LinkedIn: / fighting-blindness-canada
Sign-up for our monthly e-newsletter: www.fightingbl...
CONTACT US
General Inquiries: info@fightingblindness.ca
Health Information Line: 1.888.626.2995 | healthinfo@fightingblindness.ca
ABOUT FIGHTING BLINDNESS CANADA
Fighting Blindness Canada (FBC) is Canada’s leading private funder of vision research. We offer hope to Canadians by identifying the best, most promising research that is driving treatments and cures for blinding eye diseases, and by raising and stewarding funds to support this essential, sight-saving research. All of the research and educational initiatives we fund, support our goals of understanding why vision loss occurs, how it can be slowed or stopped, and how sight can be restored. Learn more about Fighting Blindness Canada: www.fightingbl...
DONATE: Support the advancement of sight-saving research, make a donation today: bit.ly/42ItLtg
29 авг 2024
